154 related articles for article (PubMed ID: 18668116)
1. Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents.
Moist LM; Foley RN; Barrett BJ; Madore F; White CT; Klarenbach SW; Culleton BF; Tonelli M; Manns BJ;
Kidney Int Suppl; 2008 Aug; (110):S12-8. PubMed ID: 18668116
[No Abstract] [Full Text] [Related]
2. Clinical practice guidelines for assessment and management of iron deficiency.
Madore F; White CT; Foley RN; Barrett BJ; Moist LM; Klarenbach SW; Culleton BF; Tonelli M; Manns BJ;
Kidney Int Suppl; 2008 Aug; (110):S7-S11. PubMed ID: 18668119
[No Abstract] [Full Text] [Related]
3. Biosimilar epoetin zeta in nephrology - a single-dialysis center experience.
Lonnemann G; Wrenger E
Clin Nephrol; 2011 Jan; 75(1):59-62. PubMed ID: 21176751
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice guidelines for supplemental therapies and issues.
Klarenbach SW; Moist LM; Foley RN; Barrett BJ; Madore F; White CT; Culleton BF; Tonelli M; Manns BJ;
Kidney Int Suppl; 2008 Aug; (110):S19-24. PubMed ID: 18668117
[No Abstract] [Full Text] [Related]
5. Challenge of effectively using erythropoiesis-stimulating agents and intravenous iron.
Kapoian T
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S21-8. PubMed ID: 19010258
[TBL] [Abstract][Full Text] [Related]
6. Anemia therapy in ESRD: time to move on.
Folkert VW; Meyer TW; Hostetter TH
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1163-4. PubMed ID: 20538832
[No Abstract] [Full Text] [Related]
7. Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S1-4. PubMed ID: 19010256
[No Abstract] [Full Text] [Related]
8. Understanding epoetin use: databases or clinical trials?
Roger SD
Nephrology (Carlton); 2007 Apr; 12(2):118-9. PubMed ID: 17371331
[No Abstract] [Full Text] [Related]
9. Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation.
Vaziri ND
Am J Med; 2012 Oct; 125(10):951-2. PubMed ID: 22795817
[No Abstract] [Full Text] [Related]
10. Dosing Penalty of Erythropoiesis-Stimulating Agents After Switching From Originator to Biosimilar Preparations in Stable Hemodialysis Patients.
Minutolo R; Borzumati M; Sposini S; Abaterusso C; Carraro G; Santoboni A; Mura C; Filiberti O; Santoro D; Musacchio R; Imperiali P; Fiorini F; De Nicola L; Russo D
Am J Kidney Dis; 2016 Jul; 68(1):170-2. PubMed ID: 26879099
[No Abstract] [Full Text] [Related]
11. Clinical practice guidelines for evaluation of anemia.
White CT; Barrett BJ; Madore F; Moist LM; Klarenbach SW; Foley RN; Culleton BF; Tonelli M; Manns BJ;
Kidney Int Suppl; 2008 Aug; (110):S4-6. PubMed ID: 18668118
[No Abstract] [Full Text] [Related]
12. Update on clinical practice recommendations and new therapeutic modalities for treating anemia in patients with chronic kidney disease.
Grabe DW
Am J Health Syst Pharm; 2007 Jul; 64(13 Suppl 8):S8-14; quiz S23-5. PubMed ID: 17591995
[TBL] [Abstract][Full Text] [Related]
13. Introduction to the Canadian Society of Nephrology clinical practice guidelines for the management of anemia associated with chronic kidney disease.
Manns BJ; White CT; Madore F; Moist LM; Klarenbach SW; Barrett BJ; Foley RN; Culleton BF; Tonelli M
Kidney Int Suppl; 2008 Aug; (110):S1-3. PubMed ID: 18668115
[No Abstract] [Full Text] [Related]
14. A Woman with ESRD with Increasing Need for Erythropoietin to Maintain Hemoglobin.
Koncicki HM; Fishbane S
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1173-1175. PubMed ID: 28522653
[No Abstract] [Full Text] [Related]
15. Tips for erythropoiesis-stimulating agent treatment of renal anemia.
Tomosugi N; Koshino Y
Clin Exp Nephrol; 2020 Jan; 24(1):105-106. PubMed ID: 31617026
[No Abstract] [Full Text] [Related]
16. Anemia management protocols: providing consistent hemoglobin outcomes.
Michael M
Nephrol Nurs J; 2005; 32(4):423-6. PubMed ID: 16180783
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin variability in dialysis patients.
Brimble KS; Clase CM
J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931
[No Abstract] [Full Text] [Related]
18. Anemia management under a bundled payment policy for dialysis: a preview for the United States from Japan.
Wish JB
Kidney Int; 2011 Feb; 79(3):265-7. PubMed ID: 21228798
[TBL] [Abstract][Full Text] [Related]
19. Finding a rational approach to ESA therapy--for payers and patients.
Messana A
Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
[No Abstract] [Full Text] [Related]
20. A comprehensive vision for intravenous iron therapy.
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
